PDD Holdings Inc. American Depositary Shares vs 10X Genomics Inc — how do they compare? PDD Holdings Inc. American Depositary Shares trades at $81.05 (market cap $111.40B), while 10X Genomics Inc trades at $81.8 (market cap $10.07B). The key difference: PDD Holdings Inc. American Depositary Shares is far larger — about 11.1× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, PDD Holdings Inc. American Depositary Shares nearer its low. Which is the better fit depends on your goals.
| PDD | TXG | |
|---|---|---|
Market Cap | $111.40B | $10.07B |
Volume | 4,823,275 | 5,657,286 |
Sector | Consumer Cyclical | Health |
52-Week High | $138.13 | $97.74 |
52-Week Low | $73.30 | $11.48 |
Enterprise Value | $44.04B | $9.59B |
Typical Hold Time | — | 92 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. Its sourcing, logistics, and fulfillment network supports those businesses and their commerce operations.
Read more on PDD →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →